These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1481 related articles for article (PubMed ID: 9625909)

  • 41. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.
    Newman PM; Wanzira H; Tumwine G; Arinaitwe E; Waldman S; Achan J; Havlir D; Rosenthal PJ; Dorsey G; Clark TD; Cohan D
    Malar J; 2009 Nov; 8():254. PubMed ID: 19912657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intermittent presumptive treatment of malaria to prevent low birth weight in newborns in a cohort of pregnant women from a malaria endemic area.
    Alusala DN; Estambale BB
    East Afr Med J; 2009 Aug; 86(8):378-86. PubMed ID: 20575312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The burden of malaria infection on pregnant women and birth weight of infants in south western Nigeria.
    Akanbi OM; Odaibo AB; Ademowo OG
    East Afr J Public Health; 2009 Apr; 6(1):63-8. PubMed ID: 20000067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
    Taylor SM; Levitt B; Freedman B; Madanitsa M; Thwai KL; Kalilani-Phiri L; Khairallah C; Mwapasa V; Ter Kuile FO; Meshnick SR
    J Infect Dis; 2020 Jul; 222(4):661-669. PubMed ID: 32221555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).
    Likwela JL; D'Alessandro U; Lokwa BL; Meuris S; Dramaix MW
    Trop Med Int Health; 2012 Mar; 17(3):322-9. PubMed ID: 22212628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
    Tutu EO; Lawson B; Browne E
    Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis.
    Chico RM; Cano J; Ariti C; Collier TJ; Chandramohan D; Roper C; Greenwood B
    Trop Med Int Health; 2015 Dec; 20(12):1621-33. PubMed ID: 26325263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
    Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P
    PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malaria Infection Is Common and Associated With Perinatal Mortality and Preterm Delivery Despite Widespread Use of Chemoprevention in Mali: An Observational Study 2010 to 2014.
    Mahamar A; Andemel N; Swihart B; Sidibe Y; Gaoussou S; Barry A; Traore M; Attaher O; Dembele AB; Diarra BS; Keita S; Dicko A; Duffy PE; Fried M
    Clin Infect Dis; 2021 Oct; 73(8):1355-1361. PubMed ID: 33846719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
    Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
    Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study.
    van Eijk AM; Ayisi JG; ter Kuile FO; Otieno JA; Misore AO; Odondi JO; Rosen DH; Kager PA; Steketee RW; Nahlen BL
    Trop Med Int Health; 2004 Mar; 9(3):351-60. PubMed ID: 14996364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
    Taylor SM; Antonia AL; Chaluluka E; Mwapasa V; Feng G; Molyneux ME; ter Kuile FO; Meshnick SR; Rogerson SJ
    Clin Infect Dis; 2012 Jul; 55(1):42-50. PubMed ID: 22441649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin.
    Denoeud L; Fievet N; Aubouy A; Ayemonna P; Kiniffo R; Massougbodji A; Cot M
    Malar J; 2007 Mar; 6():27. PubMed ID: 17341298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
    Valea I; Tinto H; Drabo MK; Huybregts L; Sorgho H; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Kolsteren P; D'Alessandro U;
    Malar J; 2012 Mar; 11():71. PubMed ID: 22433778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas.
    Garner P; Brabin B
    Bull World Health Organ; 1994; 72(1):89-99. PubMed ID: 8131256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study.
    Unger HW; Rosanas-Urgell A; Robinson LJ; Ome-Kaius M; Jally S; Umbers AJ; Pomat W; Mueller I; Kattenberg E; Rogerson SJ
    Malar J; 2019 Sep; 18(1):302. PubMed ID: 31477117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.
    Waltmann A; McQuade ETR; Chinkhumba J; Operario DJ; Mzembe E; Itoh M; Kayange M; Puerto-Meredith SM; Mathanga DP; Juliano JJ; Carroll I; Bartelt LA; Gutman JR; Meshnick SR
    EBioMedicine; 2022 Mar; 77():103871. PubMed ID: 35217408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.